Project development stages
Antibiotics, other therapeutics and vaccines, CARB-X funds projects from Hit-to-Lead into Phase 1, generally restricting CARB-X support for clinical evaluation to include Phase 1 single ascending dose/multiple ascending dose evaluations in healthy volunteers (and in certain situations, patients). For a description of the development phases in scope for antibiotics and therapeutics, please click here. A description of development phases in scope for vaccines and biotherapeutics is COMING SOON.
Diagnostics, CARB-X funds projects from Feasibility Demonstration to System Integration and Testing. For a description of the development phases in scope for diagnostics, please click here. (UPDATES COMING SOON)
Please note that the scope definitions will be refined prior to the opening of the specific round.
- Slides of CARB-X 2019 Funding Rounds that include information on the scope and application process, as well as CARB-X’s new cost-share provisions, as discussed in a May 16, 2019, webinar.
- For specific questions about the application process, scope of funding or contractual requirements, please contact email@example.com